KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 246 filers reported holding KARUNA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,336 | -15.8% | 7,899 | +8.0% | 0.01% | -15.4% |
| Q2 2023 | $1,586 | +95.1% | 7,315 | +63.4% | 0.01% | +85.7% |
| Q1 2023 | $813 | -16.6% | 4,478 | -9.8% | 0.01% | -22.2% |
| Q4 2022 | $975 | -99.9% | 4,962 | +1.9% | 0.01% | -18.2% |
| Q3 2022 | $1,095,000 | +108.2% | 4,869 | +17.2% | 0.01% | +120.0% |
| Q2 2022 | $526,000 | +14.1% | 4,155 | +14.3% | 0.01% | +25.0% |
| Q1 2022 | $461,000 | -55.0% | 3,634 | -53.5% | 0.00% | 0.0% |
| Q4 2021 | $1,024,000 | +112.0% | 7,818 | +98.0% | 0.00% | 0.0% |
| Q3 2021 | $483,000 | +1.0% | 3,949 | -5.8% | 0.00% | 0.0% |
| Q2 2021 | $478,000 | +77.0% | 4,192 | +86.7% | 0.00% | -60.0% |
| Q1 2021 | $270,000 | +7.6% | 2,245 | -9.1% | 0.01% | 0.0% |
| Q4 2020 | $251,000 | -9.4% | 2,469 | -0.6% | 0.01% | -23.1% |
| Q2 2020 | $277,000 | – | 2,483 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
| Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
| First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
| Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
| MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
| PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
| Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
| Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
| Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
| CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |